ConductScience.org, home

Paper36864985

Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomes.

Zhuxiao R and 10 others. EClinicalMedicine, 2023. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomes. Papers, record 36864985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36864985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomes.
PubMed
Journal
EClinicalMedicine
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
2.86
iCite
Revised in PubMed
2023-03-04
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhuxiao RRen
2Fang XXu
3Wei WWei
4Shumei YYang
5Jianlan WWang
6Qiuping LLi
7Jingjun PPei
8Chuan NNie
9Yongsheng LLi
10Zhichun FFeng
11Jie YYang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02999373Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm NeonatesDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133936055Mesenchymal Stromal Cell-Derived Extracellular Vesicles Restore Thymic Architecture and T Cell Function Disrupted by Neonatal Hyperoxia.Front Immunol2021https://conductscience.org/library/papers/33936055PubMed
234450109Birthweight and patterns of postnatal weight gain in very and extremely preterm babies in England and Wales, 2008-19: a cohort study.Lancet Child Adolesc Health2021https://conductscience.org/library/papers/34450109PubMed
334150035Safety and feasibility of umbilical cord blood collection from preterm neonates after delayed cord clamping for the use of improving preterm complications.Am J Transl Res2021https://conductscience.org/library/papers/34150035PubMed
434702946Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms.Cell Res2021https://conductscience.org/library/papers/34702946PubMed
529654158Variability of Very Low Birth Weight Infant Outcome and Practice in Swiss and US Neonatal Units.Pediatrics2018https://conductscience.org/library/papers/29654158PubMed
627957795Refining anti-inflammatory therapy strategies for bronchopulmonary dysplasia.J Cell Mol Med2017https://conductscience.org/library/papers/27957795PubMed
730995069The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach.Am J Respir Crit Care Med2019https://conductscience.org/library/papers/30995069PubMed
833389073Assessment of early nutritional intake in preterm infants with bronchopulmonary dysplasia: a cohort study.Eur J Pediatr2021https://conductscience.org/library/papers/33389073PubMed
934338792Assessment of Neonatal Intensive Care Unit Practices, Morbidity, and Mortality Among Very Preterm Infants in China.JAMA Netw Open2021https://conductscience.org/library/papers/34338792PubMed
1029459939Cognitive Outcomes of Children Born Extremely or Very Preterm Since the 1990s and Associated Risk Factors: A Meta-analysis and Meta-regression.JAMA Pediatr2018https://conductscience.org/library/papers/29459939PubMed
1128971976Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia.Am J Physiol Lung Cell Mol Physiol2017https://conductscience.org/library/papers/28971976PubMed
1231434652Association of China's universal two child policy with changes in births and birth related health factors: national, descriptive comparative study.BMJ2019https://conductscience.org/library/papers/31434652PubMed
1333554092Respiratory distress syndrome and bronchopulmonary dysplasia after fetal growth restriction: Lessons from a natural experiment in identical twins.EClinicalMedicine2021https://conductscience.org/library/papers/33554092PubMed
1431727986Bronchopulmonary dysplasia.Nat Rev Dis Primers2019https://conductscience.org/library/papers/31727986PubMed
1535455954Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns.Cells2022https://conductscience.org/library/papers/35455954PubMed
1630801637Associations of Maternal Diabetes and Body Mass Index With Offspring Birth Weight and Prematurity.JAMA Pediatr2019https://conductscience.org/library/papers/30801637PubMed
1735526524Mode of Delivery and Incidence of Bronchopulmonary Dysplasia: Results from the Population-Based EPICE Cohort.Neonatology2022https://conductscience.org/library/papers/35526524PubMed
1824472891Bronchopulmonary dysplasia: structural challenges and stem cell treatment potential.Adv Neonatal Care2014https://conductscience.org/library/papers/24472891PubMed
192772439Sample size tables for logistic regression.Stat Med1989https://conductscience.org/library/papers/2772439PubMed
2024508444Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial.J Pediatr2014https://conductscience.org/library/papers/24508444PubMed

See all 36 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42842168Mesenchymal Stem Cell (MSC)-based therapies for neonatal lung and brain injury - one size fits all?Mol Cell Pediatr2026https://conductscience.org/library/papers/42842168PubMed
42522264Five-year follow-up of phase II trial of autologous cord blood mononuclear cells for bronchopulmonary dysplasia prevention in very preterm infants.Stem Cells Transl Med2026https://conductscience.org/library/papers/42522264PubMed
42047971Autologous Cord Blood Mononuclear Cells Modulate Immunity and the Microbiota in Very Preterm Twins: A Randomized Trial.Stem Cell Rev Rep2026https://conductscience.org/library/papers/42047971PubMed
41522418An Interventional Study on the Late Treatment of Severe Bronchopulmonary Dysplasia in Preterm Infants Using Mesenchymal Stromal Cells.Stem Cells Int2026https://conductscience.org/library/papers/41522418PubMed
41158864Human OPN-derived peptide SV prevents BPD model through interacting with KIF5B to repair mitochondrial damage and inhibit apoptosis.iScience2025https://conductscience.org/library/papers/41158864PubMed
41021185Application of Umbilical Cord Blood for the Clinical Prevention and Treatment of Complications in Preterm Infants(Review).Stem Cell Rev Rep2026https://conductscience.org/library/papers/41021185PubMed
40935787Unraveling Optimal Dose and Responsive Markers for Human Cord Blood Derived Mononuclear Cells in Alleviating Bronchopulmonary Dysplasia in Neonatal Mice.Int J Stem Cells2025https://conductscience.org/library/papers/40935787PubMed
39449014Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasia.Respir Res2024https://conductscience.org/library/papers/39449014PubMed
38819251Umbilical cord blood-derived therapy for preterm lung injury: a systematic review and meta-analysis.Stem Cells Transl Med2024https://conductscience.org/library/papers/38819251PubMed
38773627Human Muse cells isolated from preterm- and term-umbilical cord delivered therapeutic effects in rat bleomycin-induced lung injury model without immunosuppressant.Stem Cell Res Ther2024https://conductscience.org/library/papers/38773627PubMed
38736551Antimicrobial peptide LL37 and regulatory T cell associated with late-onset sepsis in very preterm infants.iScience2024https://conductscience.org/library/papers/38736551PubMed
38528484Umbilical cord blood cell characteristics in very preterm neonates for autologous cell therapy of preterm-associated complications.BMC Pediatr2024https://conductscience.org/library/papers/38528484PubMed
37997800Cord blood stem cell‑derived Angptl7 ameliorates the severity of bronchopulmonary dysplasia via anti‑inflammatory and proangiogenic effects.Mol Med Rep2024https://conductscience.org/library/papers/37997800PubMed
37623531Progress in Research on Stem Cells in Neonatal Refractory Diseases.J Pers Med2023https://conductscience.org/library/papers/37623531PubMed
37603845Allogeneic Cell Therapy Applications in Neonates: A Systematic Review.Stem Cells Transl Med2023https://conductscience.org/library/papers/37603845PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36864985

GET https://conductscience.org/api/papers/v1/36864985/references?page=2